BioMed Research International
Volume 2015 (2015), Article ID 412530, 11 pages
http://dx.doi.org/10.1155/2015/412530

Research Article

Considerable Variation of Antibacterial Activity of Cu Nanoparticles Suspensions Depending on the Storage Time, Dispersive Medium, and Particle Sizes

Olga V. Zakharova,¹ Anna Yu. Godymchuk,2,3 Alexander A. Gusev,1,2 Svyatoslav I. Gulchenko,² Inna A. Vasyukova,¹ and Denis V. Kuznetsov²

¹Tambov State University named after G.R. Derzhavin, 33 Internatsionalnaya street, Tambov 392000, Russia
²National University of Science and Technology “MISIS”, 4 Leninsky pr., Moscow 119991, Russia
³National Research Tomsk Polytechnic University, 30 Lenina Avenue, Tomsk 634050, Russia

Received 28 November 2014; Revised 29 April 2015; Accepted 14 May 2015

Academic Editor: Petros Gikas

Copyright © 2015 Olga V. Zakharova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Suspensions of Cu nanoparticles are promising for creating the new class of alternative antimicrobial products. In this study we examined copper nanoparticles of various sizes obtained by the method of wire electric explosion: nanopowder average size 50 nm (Cu 50) and 100 nm (Cu 100). The paper presents the complex study of the influence of physicochemical properties such as particle size and concentration of the freshly prepared and 24-hour suspensions of Cu nanoparticles in distilled water and physiological solution upon their toxicity to bacteria E. coli M-17. Ionic solution of Cu²⁺ and sodium dichloroisocyanurate was used for comparison study. It has been shown that decrease in the nanoparticle size leads to changes in the correlation between toxicity and concentration as toxicity peaks are observed at low concentrations (0.0001⋯0.01 mg/L). It has been observed that antibacterial properties of Cu 50 nanoparticle suspensions are ceased after 24-hour storage, while for Cu 100 suspensions no correlation between antibacterial properties and storage time has been noted. Cu 100 nanoparticle suspensions at 10 mg/L concentration display higher toxicity at substituting physiological solution for water than Cu 50 suspensions. Dependence of the toxicity on the mean particle aggregates size in suspension was not revealed.

1. Introduction

Nanotechnologies are expected to be developed at medicine, microelectronics, optics, catalysis, sensor analysis, and other manufacturing sectors [1–4]. Nowadays, creation of a new class of alternative antimicrobial agents may be one of the promising applications for metal nanoparticles [5–7] because of the increasing of antibiotic resistance in microorganisms [8, 9] presenting grave hazard for public healthcare [10].

At the present time a considerable number of papers studying antibacterial properties of metal nanoparticles [11, 12] pose a wide spectrum of antibacterial activity without resistance development in microbes [13–19]. Meanwhile, due to high biological activity, comparatively low cost, and ecological safety, copper nanoparticles can be considered as promising multifunctional antibacterial agents [20].

Several authors showed that nanosized cuprum particles display antimicrobial activity towards wide range of microorganisms, including pathogenic bacteria [21, 22]. It is important to note that antibacterial properties are displayed by cuprum nanoparticles [23–25], cuprum compounds [26–30], and complex nanomaterials containing cuprum [31–34].

Cytotoxicity of Cu nanoparticles results not only from the small size of the particles, high specific surface value, and close interaction with microbial membranes but also from formation of leached cuprum-peptide complexes leading to several-fold increase in reactive oxygen intermediate (ROI) generation, cell viability decrease, and general biomass growth suppression [35]. Storage of cuprum nanoparticle suspensions for some time may lead to Cu²⁺ ions release into the culture medium, as cuprum has high reaction activity [36].

It was also found that cuprum nanoparticles display on the one hand low toxicity towards humans and on the other hand show high antimicrobial effect towards the cells of test-cultures of gram-positive and gram-negative bacteria which makes them applicable for creating the new wound healing products [22]. By the example of E. coli it was shown that utilization of Cu nanoparticles is of high potential for creating new bactericidal dressings as human tissues are resistant to cuprum [37], while microorganisms are highly sensitive to it [38–40].

However, creation of such products is hampered by the lack of experimental data on the biological activity alteration when passing the upper nanoscale limit (100 nm) and at transferring from ion-molecule form to nanoscale through the lower limit (10 nm).

Studies of nanoparticle antimicrobial properties have made it possible to discover possible mechanisms of their toxic action including oxidative stress due to reactive oxygen intermediates generation, lipid peroxidation, protein oxidation and DNA degradation in cells, mechanical damage of cell membranes [41], and influence of some physicochemical characteristics such as size, shape, and production method upon the level of biocidal impact [5, 23, 42–45].

At the same time such factors as agglomeration and rapid oxidation have made this research area difficult. Although, some researches use stabilizers in order to eliminate these factors [46–48], joint use of nanoparticles and stabilizers may lead to synergistic effects. Besides, nanoparticle antibacterial properties are usually studied in vitro in water or agarous media but not in biological fluids. Moreover, dependence of nanoparticle suspensions toxicity upon their storage time is still unstudied. Thus, mechanisms which are connected with nanoparticles behavior in colloidal systems and essential for cytotoxicity are still undiscovered.

This paper shows alteration of copper nanoparticles bactericidal properties depending on physicochemical characteristics of the particles, dispersive medium, and suspension storage time.

2. Materials and Methods

2.1. Nanoparticles

In this study we examined copper nanoparticles of various sizes obtained by the method of wire electric explosion in Ar-medium with additive of H₂ (10 vol. %) at the pressure of 1.52·10⁵ Pa, capacitive storage charging voltage −24 kV (the wire diameter 0.3 mm, length 75 mm). To maintain metal stability to oxidation nanopowders were passivated by slow air oxidation (Advanced Powder Technologies LLC, Tomsk, Russian Federation [49]). According to the manufacturer arithmetic average size of the particles was 50 nm (Cu 50, specific surface area 12 m²/g) and 100 nm (Cu 100, specific surface area 6.8 m²/g); the nanoparticles were spherical in shape (Figures 1 and 2).

Figure 1: Electron micrograph of Cu 50 nanoparticles powders.

Figure 2: Electron micrograph of Cu 100 nanoparticles powders.

On the assumption that the shape of the particles is almost spherical, thickness of the oxidation film on the particle surface was calculated using the following formulas:

where is the particle radius, is the particle volume, is the volume of the metallic sphere, is the radius of the metallic part, and is the radius of the particle coated with oxidation film.

The calculation results for oxidation film for the initial samples are presented in Table 1.

Table 1: Values of oxidation film thickness for cuprum nanoparticles.

Sample
Oxygen content, %
Oxidation film thickness, nm

Cu 50
5.1
0.6

Cu 100
6.3
1.5

The powders were stored in sealed glass vials at the temperature of °С; the vials were opened not earlier than a week before the suspension preparation.

2.2. Nanoparticles Suspensions

The nanoparticle suspensions were prepared with doubly distilled water (рН = ,) and 9% NaCl solution (рН  ). Precisely weighed quantities were determined using ViBRA HT analytical balance (Shinko Denshi, Japan, with precision ±0.0001 g), poured into extemporaneously prepared dispersion vehicle and stirred with a glass rod for 20 seconds. After stirring the suspensions were processed in Ultrasonic Cleaner CD-4800 (Codyson, China) for 40 seconds (70 W, 44 Hz, volume 1.4 L). Initial copper concentration in the solutions was 10 mg/L; the initial solutions were then diluted with doubly distilled water or physiological solution to prepare suspensions with copper concentrations of 1, 0.1, 0.01, 0.001, and 0.0001 mg/L.

The laboratory glassware for sample storage and biotesting was washed with mixture of potassium bichromate and sulphuric acid (chromic-sulphuric acid mixture). The glassware inner surfaces were gently wetted with chromic-sulphuric acid mixture and left for 2-3 hours; the glassware was then washed thoroughly with tap water, disacidified with sodium bicarbonate solution, and washed for 3-4 times with doubly distilled water.

Toxic properties were analyzed in freshly prepared (stored for no more than 1 hour) and stored for no more than 24-hour suspensions.

2.3. Comparison Solutions

2.3.1. Cu²⁺ Ion Solutions

Solutions containing Cu²⁺ ions were used for comparison. Solutions were prepared by dissolving copper chloride (CuCl₂    2H₂O, GOST 4167-74, Russian Federation) in doubly distilled water (рН = ) with conductivity of 0.2 μS and in physiological solution (рН  ).

2.3.2. Sodium Dichloroisocyanurate Solutions

Aqueous solutions of sodium dichloroisocyanurate (C₃Cl₂N₃NaO₃, SDC) (NPF Praktika LLC, Russian Federation) were employed for positive control; they were also prepared with doubly distilled water and physiological solution. Sodium dichloroisocyanurate is widely used as a disinfectant efficient against gram-positive and gram-negative bacteria, viruses, Candida fungus, and dermatophytes [50].

Solutions of Cu²⁺ ions and sodium dichloroisocyanurate were prepared within concentration range of 0.000110 mg/L.

2.4. Toxicity Evaluation

Copper nanoparticle solutions toxicity was measured by bioluminescence technique used for microbiological and molecular genetic evaluation of nanomaterials influence on microbiocenosis species [51–54]. The method measures modifications in bioluminescence intensity of the genetically modified photobacteria strain E. coli M-17 influenced by nanoparticles present in the analyzed sample as compared with the control sample. Alteration in the bioluminescence intensity of the tested object in the analyzed sample as compared with the control sample containing no toxic agents was taken as effect criterion. Bioluminescence intensity reduces in proportion to toxic effect.

Toxic effect of the studied nanomaterial sample upon bacteria is determined by their bioluminescence inhibition after 30-minute exposure period. The quantitative test-reaction parameter assessment is expressed as a toxicity index which is a nondimensional quantity determined from the formula , where and are luminous intensities of the control and tested samples accordingly, while the exposition time of the examined sample with the test-object is fixed.

The technique allows for three threshold levels of the toxicity index:

(1)acceptable degree when toxicity index is in the range from 0 to 20;(2)medium degree when toxicity index is in the range from 20 to 50;(3)high degree when toxicity index equals or is higher than 50.

Negative toxicity index values are regarded as nontoxicity.

In the process of toxicity index evaluation parallel measurements of control and studied samples were carried out. For higher data reliability the number of repeat sample tests was increased up to 5 measurements.

The measurements were carried out using Biotox-10 specialized luminometer (Russian Federation). The first test phase was carried out straight after the solutions were prepared; the second phase was carried out in 24 hours. The solutions pH value was checked before each measurement using digital pH-meter рН-2005 SELECTA (Barcelona, Spain).

2.5. Measurement of the Dispersity

The particle/aggregate size distribution in the prepared suspensions was evaluated at the temperature of 25°С using the dynamic light scattering technique and the Malvern Zetasizer Nano device, USA (a helium-neon laser with the power of 4 mW and the 633 nm wave length). For these measurements, a versatile capillary U-shaped polystyrene cuvette was used. The dry cuvette was delicately washed with distilled water; then 1 mL of the suspension under study was poured in, avoiding air bubbles formation. Each measurement was repeated thrice. Based on the obtained size distribution; the average particle size at each point was calculated according to the following formula:

where represents the particle size in dispersion and is the differential percent of particles with size in the dispersion.

3. Results and Discussion

Molecules interact with macroscopic bodies’ surfaces according to the laws of molecular statistics, while in transition to nanoobjects and live cells statistics of comparatively large objects and their contact interactions acquire importance, in which case the particle roles change qualitatively: the larger ones may be considered as motionless while nanoparticles and metallic ions may be considered as more mobile than bacterial cells, as their dimensions (1–100 nm) are smaller than average E. coli cell size (1–3 μm in length, 0.5–0.8 μm in width). Owing to the fact that reactivity of the solids is in proportion to their surface area, other factors, including concentration being equal, the choice of copper configurations such as 50 nm and 100 nm copper suspensions and Cu²⁺ containing solutions, were justifiable for the study. Presumably high biological activity per unit mass was to be observed for all the chosen configurations as compared to larger particles.

3.1. Study of the Antibacterial Properties of Cu 50 Nanoparticle Suspensions

The study of the antibacterial properties of 0.5-hour aqueous Cu 50 nanoparticle suspensions has allowed us to discover that toxicity observed at the lowest concentrations of 0.0001 mg/L decreases from 40 to 20 units with nanoparticle concentration growth up to 0.01 mg/L, no toxicity is observed in suspensions with 0.11 mg/L concentration, and the maximum value (≈50 units) is recorded at 10 mg/L suspension (Figure 3(a)). The solutions pH value monitoring throughout the testing process indicated slight deviation of pH up to 7.6 from the normal values of 6.8–7.4 specifically in suspensions with 0.0001 and 0.001 mg/L concentrations (Table 2). The highest value of toxicity index in 10 mg/L suspension may be connected with increased concentration of Cu²⁺ ions dispersed in the solution as a result of the sample dissolution during its hour-long exposure [35, 55].

Table 2: рН value of Cu 50 nanoparticle suspensions.

Concentration (mg/L)
Cu 50 + H₂O (0.5 h)
Cu 50 + H₂O (24 h)
Cu 50 + PS (0.5 h)
Cu 50 + PS (24 h)

0.0001
7.6
7.0
7.2
7.1

0.001
7.6
7.1
7.2
7.1

0.01
7.3
7.1
7.1
7.2

0.1
7.3
7.2
7.1
7.2

1
7.3
7.2
7.2
7.2

10
7.4
7.2
7.3
7.2

(a)

(b)

Figure 3: Changes in the toxicity index for Cu 50 nanoparticle suspensions based on (a) water, Cu 50 + H₂O, and (b) physiological solution, Cu 50 + PS.

According to the experiment, 24-hour suspensions of Cu 50 particles display no antibacterial effect (Figure 3(a)) in the studied concentration interval. Lack of toxicity may be explained by the storage period as copper particles with size < 150 nm may oxidize to 11–14 wt.% developing on the surface oxide-hydroxide forms of copper blocking further dissolution [55].

Within the studied concentration range toxicity index for physiological solution (PS) medium displays the highest values in 0.5-hour suspensions at particle concentrations of 0.01 mg/L (>50 units) and 10 mg/L (≈30 units) (Figure 3(b)). 24-hour Cu 50 nanoparticle suspensions in physiological solution display no toxic effect on the tested object. Thus, the highest toxic effect is observed in freshly prepared Cu 50 nanoparticle suspensions. Minimum inhibitory concentrations (MIC) and Minimum bactericidal concentrations (MBC) were evaluated by means of the computational method [56]. Neither MIC nor MBC could be calculated for Cu 50 nanoparticles because of the nonlinear type of the dependence.

Dispersion analysis of 0.5-hour aqueous Cu 50 nanoparticle suspensions showed insignificant alteration in particle aggregates sizes ; slight growth of from 177 to 250–270 nm was observed with concentration increase. In 24 hours of aggregates in suspensions decreases slightly; it may be connected with larger aggregates subsidence (Figure 4(a)). In physiological solution a tendency towards increase of of the aggregates in 0.5-hour solutions from 108 to 226 nm was observed together with increase in concentration from 0.0001 to 10 mg/L, respectively (Figure 4(b)). In 24 hours value changes insignificantly.

(a)

(b)

Figure 4: Changes in average size of Cu 50 nanoparticle suspensions based on (a) water, Cu 50 + H₂O, and (b) physiological solution, Cu 50  +  PS.

Comparison of toxicological and dispersion analysis data leads to suggestion that size of aggregates insignificantly changing with storage time and concentration growth is not the main reason for variations in antibacterial properties. It is probable that chemical state of the surface is much more important for toxicity level variations than dispersity.

3.2. Study of the Antibacterial Properties of Cu 100 Nanoparticle Suspensions

According to the data obtained from bioluminescence technique aqueous Cu 100 nanoparticle suspensions show no toxic effect on bacteria in the studied range of concentrations (Figure 5(a)). The same properties are characteristic for PS suspensions, excluding 10 mg/L suspensions where medium toxicity level of 35–50 units is observed (Figure 5(b)).

(a)

(b)

Figure 5: Changes in the toxicity index for Cu 100 nanoparticle suspensions based on (a) water, Cu 100 + H₂O, and (b) physiological solution, Cu 100 + PS.

Minimum inhibitory concentration (MIC) was assessed for physiological solution: it is 4 mg/L for the freshly prepared suspension and 5 mg/L for the 24-hour suspension. Minimum bactericidal concentration (MBC) was not detected in the studied range of concentrations.

Data obtained from рН measurements display that slight shift in pH value up to 7.7 is observed only in 10 mg/L PS suspensions of Cu 100 nanoparticles (Table 3).

Table 3: pH value of the studied Cu 100 nanoparticle suspensions.

Concentrations (mg/L)
Cu 100 + H₂O (0.5 h)
Cu 100 + H₂O (24 h)
Cu 100 + PS (0.5 h)
Cu 100 + PS (24 h)

0.0001
7.0
7.1
7.0
7.4

0.001
7.2
7.1
7.1
7.4

0.01
7.3
7.2
7.1
7.5

0.1
7.3
7.2
7.1
7.4

1
7.3
7.2
7.1
7.4

10
7.2
7.4
7.7
7.2

Comparative analysis of bactericidal properties of the particles in H₂O and PS media shows increase of toxicity index in the presence of electrolyte. The received data corresponds with the previous experiments stating that presence of more polar solvent (Cl⁻ ions) increases the degree of Cu 100 particles dissolution [55]. Detachment of large amount of Cu²⁺ ions having higher diffusion activity than solid particles may lead to increase in cytotoxicity.

According to the data obtained from dynamic light scattering technique storage time and concentration have more effect on degree of aggregation in Cu 100 nanoparticle suspensions than they do in Cu 50 nanoparticle suspensions. In aqueous Cu 100 suspensions when concentration increases from 0.1 to 1 mg/L of the aggregates becomes 1.5–2 times smaller regardless of the storage time (Figures 6(a) and 6(b)). In concentrated suspensions with 10 mg/L of the aggregates rises sharply while their storage for more than 24 hours has little effect on which can be explained by the particles settling (Figure 6(a)). In PS suspensions of the aggregates gradually increases together with particles concentration growth. Increase in storage time for PS suspensions resulted in no significant aggregation (Figure 6(b)).

(a)

(b)

Figure 6: Changes in average size of Cu 100 nanoparticle suspensions based on (a) water, Cu 100 + H₂O, and (b) physiological solution, Cu 100 + PS.

Comparison of the toxic properties of nanoparticles of various sizes shows that decrease in nanoparticle size from 100 to 50 nm leads to sharp rise of toxicity index; this effect is especially characteristic for diluted suspension with copper concentration < 0.01 mg/L. Since aggregate size has almost now influence on biological activity variation it may be concluded that particle size decrease leads to toxicity growth because of increasing number of surface atoms which have higher activity due to unsaturated bonds. Thus, for example, nanoparticles are characterized by high surface atoms to volume ratio. This fact may be of great significance for the whole spectrum of the properties displayed by a substance including its chemical, physicochemical, and biological activity [57].

At the same time, the team obtained evidence that in 24 hours activity of Cu 50 nanoparticles decreased in comparison with that of Cu 100 nanoparticles. Since the size of the particles/aggregates does not change much (Figures 4 and 6), such difference in behavior can be explained by peculiarities of chemical composition of the surface layers of the particles composing the aggregates in water suspensions. In the work quoted previously [55] it was shown by the example of similar objects of study (electroexplosive cuprum nanoparticles) that during the first hours of exposition in water the specific rate of metallic ions release from Cu 50 nanoparticles is much lower than that from Cu 100 nanoparticles. The mechanism suggested by the authors implies that low-solubility oxide-hydroxide cuprum compounds, inseparable by centrifugation, are formed on the surface with time, while the dissolution rate differs by 1-2% wt. Thus, we can suggest that in spite of formation of a hard phase new composition on the surface of particles there still remains high content of highly toxic Cu²⁺ ions in Cu 100 suspension; these ions are responsible for high toxicity of larger particles after 24 h exposure.

3.3. Study of Cu²⁺ Ions Solutions Toxicity

It is deduced from experiments that Cu²⁺ solutions with concentration ≤ 1 mg/L display no cytotoxicity (Figures 7(a) and 7(b)). High toxicity level (>90 units) is observed at 10 mg/L concentration, while storage time influence upon bactericidal effect is noted only for PS-based solutions: toxic effect disappears after 24-hour storage. Minimum inhibitory concentration (MIC) for water solutions and for fresh suspension based on physical solution is 2 mg/L. Minimum bactericidal concentration (MBC) for water solutions is 10 mg/L; for fresh suspension based on physical solution it is 10 mg/L. For 24-hour suspension based on physical solution neither MIC nor MBC were calculated.

(a)

(b)

Figure 7: Changes in the toxicity index for Cu²⁺ solutions in (a) water, Cu²⁺ + H₂O and (b) physiological solution, Cu²⁺ + PS.

Change in pH level of the solutions has no influence on their toxicity value as the highest deviation from the norm produces no biocidal effect (Table 4).

Table 4: pH levels of Cu²⁺ solutions.

Concentrations (mg/L)
Cu²⁺ + H₂O (0.5 h)
Cu²⁺ + H₂O (24 h)
Cu²⁺ + PS (0.5 h)
Cu²⁺ + PS (24 h)

0.0001
7.2
7.2
7.1
7.2

0.001
7.2
7.3
7.2
7.2

0.01
7.2
7.3
7.1
7.3

0.1
7.2
7.2
7.1
7.2

1
7.1
7.1
7.0
7.1

10
6.7
7.1
6.6
6.3

One can reasonably suggest that on the one hand high toxicity of Cu²⁺ solutions at 10 mg/L concentration can be connected with reaching some threshold concentration of Cu²⁺ ions when high concentration gradient leads to increasing amount of ions diffusing into the cell through cytoplasmic membrane. On the other hand, aqueous Cu²⁺ solutions in neutral and weak basic media are characterized by some degree of instability. According to pH measurements pH values decreased from 7.2 to 6.36.6 units (Table 4), which had to increase the hydrolytic stability of the solutions. With increase in the solution concentration up to 10 mg/L the concentrations product Cu(OH)₂ will exceed the dissociation constant; consequently the deposited amorphous particles of copper hydroxides can adhere to the cell surface leading to membrane permeability deterioration thus disrupting the cell life functions.

3.4. Control Toxicity check In Bactericidal Solution of SDC

The control study of the influence of widely employed antibacterial agent shows that toxicity index has negative or zero values at substance concentration 1 mg/L. It can be decisively stated that only at concentrations exceeding this value almost complete biosensor luminescence quenching is observed in all the studied media while storage time has no notable effect on the product antimicrobial properties (Figures 8(a) and 8(b)) and on initial pH value of 7.2.

(a)

(b)

Figure 8: Changes in the toxicity index for SDC solutions (C₃Cl₂N₃NaO₃) in (a) water and (b) physiological solution (PS).

Minimum inhibitory concentration (MIC) for fresh water solution is 0.25 mg/L, and for 24-hour suspension it is 2 mg/L. For suspensions based on physical solution it is 2 mg/L. Minimum bactericidal concentrations (MBC) for freshly prepared and 24-hours water solutions and for fresh suspension based on physical solution was 10 mg/L. MBC was not evaluated for 24-hour suspension based on physical solution within the studied range of concentrations.

4. Conclusion

Thus, the present work displays the influence of such factors as storage time, composition, and concentration of copper-containing solutions and suspensions upon their bactericidal effect against E. coli M-17 bacteria.

Comparative analysis of the influence of various characteristics of Cu 50 and Cu 100 nanoparticle suspensions upon their performance against E. coli enabled us to determine the most efficient concentrations (mg/L) displaying the highest antibacterial effect (Table 5).

Table 5: The most efficient concentrations (mg/L) displaying the maximum antibacterial effect.

Conditions: media and storage time
Nanoparticle suspension
Nanoparticle suspension
Cu²⁺ solution
C₃Cl₂N₃NaO₃ solution

Cu 50
Cu 100

H₂О 0.5 h
0.0001; 10
—
10
1; 10

H₂О 24 h
—
—
10
10

PS 0.5 h
0.01; 10
10
10
10

PS 24 h
—
10
—
10

Nonlinear toxicity effects.

It was determined that reduction of nanoparticles initial size from 100 to 50 nm results in rise in their antimicrobial activity; at the same time character of the dependence of toxicity on concentration also changes as toxicity peaks at low concentrations (0.00010.01 mg/L) are observed. The obtained results correspond with the available data on increased toxicity of nanoparticles of smaller size [58–60] and on nonlinear character of nanotoxicity, which may result from such factors as step-like character of adaptation of living organisms to stresses, signaling role of low-intensity nanoparticle influence, nonlinear stochastic resonance induced by weak influences [61, 62].

Furthermore, no influence of medium-sized nanoparticles/aggregates in suspensions upon their antibacterial properties was noted. It was shown that the suspensions storage time is an important factor altering antimicrobial properties of small nanoparticle suspensions of Cu 50 where toxicity decreases after 24-hour storage, while suspensions of larger Cu 100 nanoparticles display no such dependence.

It was found that dispersion medium has different influence on antibacterial properties of suspensions containing nanoparticles of different sizes: unlike Cu 50, high-concentration suspensions of Cu 100 nanoparticles (10 mg/L) display higher toxicity when physiological solution is used instead of water.

The conducted experiments enabled us to detect differences in toxicological effects of nanostructured and ionic forms of copper. In large, Cu²⁺ solutions display lower level of toxicity at concentrations of 0.00011 mg/L than Cu 50 nanoparticle suspensions. Although at the maximum concentration of 10 mg/L copper in ionic form shows the highest toxic effect comparable with that of antimicrobial product based on aqueous solution of C₃Cl₂N₃NaO₃.

The received results can be used for creating new types of antibacterial products based on nanoscale copper particles as well as for development of methods for toxicity forecasting and evaluation of aqueous solutions containing copper.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The authors gratefully acknowledge the financial support of the Ministry of Education and Science of the Russian Federation (Project no. RFMEFI57814X0080) and from the framework of Increase Competitiveness Program of NUST “MISiS” (in part of analysis of the properties of colloidal suspensions).

References

C. B. Murray, C. R. Kagan, and M. G. Bawendi, “Synthesis and characterization of monodisperse nanocrystals and close-packed nanocrystal assemblies,” Annual Review of Materials Science, vol. 30, pp. 545–610, 2000.

O. V. Salata, “Applications of nanoparticles in biology and medicine,” Journal of Nanobiotechnology, vol. 2, article 3, 2004.

M. C. Roco, C. A. Mirkin, and M. C. Hersam, “Nanotechnology research directions for societal needs in 2020: summary of international study,” Journal of Nanoparticle Research, vol. 13, no. 3, pp. 897–919, 2011.

M. Fakruddin, Z. Hossain, and H. Afroz, “Prospects and applications of nanobiotechnology: a medical perspective,” Journal of Nanobiotechnology, vol. 10, article 31, 2012.

A. Azam, A. S. Ahmed, M. Oves, M. S. Khan, S. S. Habib, and A. Memic, “Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study,” International Journal of Nanomedicine, vol. 7, pp. 6003–6009, 2012.

W. Liu, P. Su, S. Chen et al., “Synthesis of TiO₂ nanotubes with ZnO nanoparticles to achieve antibacterial properties and stem cell compatibility,” Nanoscale, vol. 6, no. 15, pp. 9050–9062, 2014.

A. Besinis, T. de Peralta, and R. D. Handy, “The antibacterial effects of silver, titanium dioxide and silica dioxide nanoparticles compared to the dental disinfectant chlorhexidine on Streptococcus mutans using a suite of bioassays,” Nanotoxicology, vol. 8, no. 1, pp. 1–16, 2014.

Antibiotic Resistance Major Public Health Problem [Digital resource], http://www.medicalnewstoday.com/articles/252956.php

Alliance for the Prudent Use of Antibiotics (APUA), What is Antibiotic Resistance and Why is it a problem? [Digital resource], http://www.tufts.edu/med/apua/about_issue/antibiotic_res.shtml

WHO, “Atibiotic resistance reveals serious, worldwide threat to public health [Digital resource],” WHO Report, World Health Organization, Media Centre, 2014, http://www.who.int/mediacentre/news/releases/2014/amr-report/ru/.

M. J. Hajipour, K. M. Fromm, A. Akbar Ashkarran et al., “Antibacterial properties of nanoparticles,” Trends in Biotechnology, vol. 30, no. 10, pp. 499–511, 2012.

Z. Huang, X. Zheng, D. Yan et al., “Toxicological effect of ZnO nanoparticles based on bacteria,” Langmuir, vol. 24, no. 8, pp. 4140–4144, 2008.

D. Roe, B. Karandikar, N. Bonn-Savage, B. Gibbins, and J.-B. Roullet, “Antimicrobial surface functionalization of plastic catheters by silver nanoparticles,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 4, pp. 869–876, 2008.

S. S. Khan, A. Mukherjee, and N. Chandrasekaran, “Studies on interaction of colloidal silver nanoparticles (SNPs) with five different bacterial species,” Colloids and Surfaces B: Biointerfaces, vol. 87, no. 1, pp. 129–138, 2011.

M. Ahamed, H. A. Alhadlaq, M. A. Khan, P. Karuppiah, and N. A. Al-Dhabi, “Synthesis, characterization, and antimicrobial activity of copper oxide nanoparticles,” Journal of Nanomaterials, vol. 2014, Article ID 637858, 4 pages, 2014.

R. Yoshida, D. Kitamura, and S. Maenosono, “Mutagenicity of water-soluble ZnO nanoparticles in Ames test,” The Journal of Toxicological Sciences, vol. 34, no. 1, pp. 119–122, 2009.

S. Maenosono, T. Suzuki, and S. Saita, “Mutagenicity of water-soluble FePt nanoparticles in Ames test,” The Journal of Toxicological Sciences, vol. 32, no. 5, pp. 575–579, 2007.

W. Jiang, H. Mashayekhi, and B. Xing, “Bacterial toxicity comparison between nano- and micro-scaled oxide particles,” Environmental Pollution, vol. 157, no. 5, pp. 1619–1625, 2009.

J. S. Kim, E. Kuk, K. N. Yu et al., “Antimicrobial effects of silver nanoparticles,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 3, no. 1, pp. 95–101, 2007.

K. Giannousi, K. Lafazanis, J. Arvanitidis, A. Pantazaki, and C. Dendrinou-Samara, “Hydrothermal synthesis of copper based nanoparticles: antimicrobial screening and interaction with DNA,” Journal of Inorganic Biochemistry, vol. 133, pp. 24–32, 2014.

M. Veerapandian, S. Sadhasivam, J. Choi, and K. Yun, “Glucosamine functionalized copper nanoparticles: preparation, characterization and enhancement of anti-bacterial activity by ultraviolet irradiation,” Chemical Engineering Journal, vol. 209, pp. 558–567, 2012.

A. A. Rakhmetova, Study of biological activity of copper nanoparticles with differing dispersion and phase composition, author’s abstract for Cand. Sc. (Biology), Moscow, Russia, 2011

I. V. Babushkina, I. A. Mamontova, and E. V. Gladkova, “Metal nanoparticles reduce bacterial contamination of experimental purulent wounds,” Bulletin of Experimental Biology and Medicine, vol. 158, no. 5, pp. 692–694, 2015.

A. K. Chatterjee, R. Chakraborty, and T. Basu, “Mechanism of antibacterial activity of copper nanoparticles,” Nanotechnology, vol. 25, no. 13, Article ID 135101, 2014.

J. Díaz-Visurraga, C. Daza, C. Pozo, A. Becerra, C. von Plessing, and A. García, “Study on antibacterial alginate-stabilized copper nanoparticles by FT-IR and 2D-IR correlation spectroscopy,” International Journal of Nanomedicine, vol. 7, pp. 3597–3612, 2012.

R. Sivaraj, P. K. Rahman, P. Rajiv, H. A. Salam, and R. Venckatesh, “Biogenic copper oxide nanoparticles synthesis using Tabernaemontana divaricate leaf extract and its antibacterial activity against urinary tract pathogen,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 133, pp. 178–181, 2014.

M. Agarwala, B. Choudhury, and R. N. S. Yadav, “Comparative study of antibiofilm activity of copper oxide and iron oxide nanoparticles against multidrug resistant biofilm forming uropathogens,” Indian Journal of Microbiology, vol. 54, no. 3, pp. 365–368, 2014.

P. Swain, S. K. Nayak, A. Sasmal et al., “Antimicrobial activity of metal based nanoparticles against microbes associated with diseases in aquaculture,” World Journal of Microbiology and Biotechnology, vol. 30, no. 9, pp. 2491–2502, 2014.

V. V. T. Padil and M. Černík, “Green synthesis of copper oxide nanoparticles using gum karaya as a biotemplate and their antibacterial application,” International Journal of Nanomedicine, vol. 8, pp. 889–898, 2013.

A. Pramanik, D. Laha, D. Bhattacharya, P. Pramanik, and P. Karmakar, “A novel study of antibacterial activity of copper iodide nanoparticle mediated by DNA and membrane damage,” Colloids and Surfaces B: Biointerfaces, vol. 96, pp. 50–55, 2012.

P. Mantecca, E. Moschini, P. Bonfanti et al., “Toxicity evaluation of a New Zn-Doped CuO nanocomposite with highly effective antibacterial properties,” Toxicological Sciences, 2015.

A. L. D. O. F. Rossetto, D. S. Vicentini, C. H. Costa, S. P. Melegari, and W. G. Matias, “Synthesis, characterization and toxicological evaluation of a core-shell copper oxide/polyaniline nanocomposite,” Chemosphere, vol. 108, pp. 107–114, 2014.

L. A. Tamayo, P. A. Zapata, F. M. Rabagliati et al., “Antibacterial and non-cytotoxic effect of nanocomposites based in polyethylene and copper nanoparticles,” Journal of Materials Science: Materials in Medicine, vol. 26, no. 3, article 129, 2015.

S. Shankar, X. Teng, and J. Rhim, “Properties and characterization of agar/CuNP bionanocomposite films prepared with different copper salts and reducing agents,” Carbohydrate Polymers, vol. 114, pp. 484–492, 2014.

C. Gunawan, W. Y. Teoh, C. P. Marquis, and R. Amal, “Cytotoxic origin of copper (II) oxide nanoparticles: comparative studies with micron-sized particles, leachate, and metal salts,” ACS Nano, vol. 5, no. 9, pp. 7214–7225, 2011.

K. Midander, I. O. Wallinder, and C. Leygraf, “In vitro studies of copper release from powder particles in synthetic biological media,” Environmental Pollution, vol. 145, no. 1, pp. 51–59, 2007.

J. J. Hostynek and H. I. Maibach, “Copper hypersensitivity: dermatologic aspects—an overview,” Reviews on Environmental Health, vol. 18, no. 3, pp. 153–183, 2003.

G. Borrow and J. Gabbay, “Putting copper into action: copper-impregnated products with potent biocidal activities,” The FASEB Journal, vol. 18, no. 14, pp. 1728–1730, 2004.

S. S. Timofeyev, “Water oxidation of Al/AlN/Cu and Al/AlN/Zn nanopowders for creating microbiologically active sorbents,” in Proceedings of the 10th International Conference of Students and Young Scientists “Prospects of Fundamental Sciences Development”, National Research Tomsk Polytechnic University, Tomsk, Russia, April 2013, http://science-persp.tpu.ru/Previous%20Materials/Konf_2013.pdf.

N. S. Heliopoulos, S. K. Papageorgiou, A. Galeou, E. P. Favvas, F. K. Katsaros, and K. Stamatakis, “Effect of copper and copper alginate treatment on wool fabric. Study of textile and antibacterial properties,” Surface & Coatings Technology, vol. 235, pp. 24–31, 2013.

N. A. Amro, L. P. Kotra, K. Wadu-Mesthrige, A. Bulychev, S. Mobashery, and G.-Y. Liu, “High-resolution atomic force microscopy studies of the Escherichia coli outer membrane: structural basis for permeability,” Langmuir, vol. 16, no. 6, pp. 2789–2796, 2000.

K. Kon and M. Rai, “Metallic nanoparticles: mechanism of antibacterial action and influencing factors,” Journal of Comparative Clinical Pathology Research, vol. 2, no. 1, pp. 160–174, 2013.

S. Pal, Y. K. Tak, and J. M. Song, “Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli,” Applied and Environmental Microbiology, vol. 73, no. 6, pp. 1712–1720, 2007.

T. Theivasanthi and M. Alagar, “Studies of copper nanoparticles effects on micro organisms,” Annals of Biological Research, vol. 2, no. 3, pp. 368–373, 2011, http://scholarsresearchlibrary.com/archive.html

I. Subhankari and P. L. Nayak, “Antimicrobial activity of copper nanoparticles synthesised by ginger (Zingiber officinale) extract,” World Journal of Nano Science & Technology, vol. 2, no. 1, pp. 10–13, 2013.

M. S. Usman, M. E. El Zowalaty, K. Shameli, N. Zainuddin, M. Salama, and N. A. Ibrahim, “Synthesis, characterization, and antimicrobial properties of copper nanoparticles,” International Journal of Nanomedicine, vol. 8, no. 1, pp. 4467–4479, 2013.

E. I. Alarcon, K. Udekwu, M. Skog et al., “The biocompatibility and antibacterial properties of collagen-stabilized, photochemically prepared silver nanoparticles,” Biomaterials, vol. 33, no. 19, pp. 4947–4956, 2012.

M. R. Shah, S. Ali, M. Ateeq et al., “Morphological analysis of the antimicrobial action of silver and gold nanoparticles stabilized with ceftriaxone on Escherichia coli using atomic force microscopy,” New Journal of Chemistry, vol. 38, no. 11, pp. 5633–5640, 2014.

Metal nanopowders [digital resource], http://www.nanosized-powders.com/

Disinfectant Nika-Chlor [digital resource], http://geniks.ru/catalog/medical/hlors/

I. Lopes, R. Ribeiro, F. E. Antunes et al., “Toxicity and genotoxicity of organic and inorganic nanoparticles to the bacteria Vibrio fischeri and Salmonella typhimurium,” Ecotoxicology, vol. 21, no. 3, pp. 637–648, 2012.

A. Garcia, S. Recillas, A. Sánchez, and X. Font, “The luminescent bacteria test to determine the acute toxicity of nanoparticle suspensions,” Methods in Molecular Biology, vol. 926, pp. 255–259, 2012.

O. A. Mogil'naia, A. P. Puzyr', and V. S. Bondar', “Growth and bioluminescence of luminous bacteria under the action of aflatoxin B1 before and after its treatment with nanodiamonds,” Prikladnaia Biokhimiia i Mikrobiologiia, vol. 46, no. 1, pp. 40–44, 2010.

A. P. Zarubina, E. P. Lukashev, L. I. Deev, I. M. Parkhomenko, and A. B. Rubin, “Biotesting the biological effects of single-wall carbon nanotubes using bioluminescent bacteria test-system,” Nanotechnologies in Russia, vol. 4, no. 11-12, pp. 871–875, 2009.

A. Y. Godymchuk, G. G. Savel'ev, and D. V. Gorbatenko, “Dissolution of copper nanopowders in inorganic biological media,” Russian Journal of General Chemistry, vol. 80, no. 5, pp. 881–888, 2010.

D. J. Finney, Probit Analysis, Cambridge University Press, Cambridge, UK, 3rd edition, 1971.

L. C. Renwick, D. Brown, A. Clouter, and K. Donaldson, “Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types,” Occupational and Environmental Medicine, vol. 61, no. 5, pp. 442–447, 2004.

S. Nair, A. Sasidharan, V. V. D. Rani, D. Menon, K. Manzoor, and S. Raina, “Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells,” Journal of Materials Science: Materials in Medicine, vol. 20, no. 1, pp. S235–S241, 2009.

G. A. Martinez-Castanon, N. Niño-Martínez, F. Martínez-Gutierrez, J. R. Martínez-Mendoza, and F. Ruiz, “Synthesis and antibacterial activity of silver nanoparticles with different sizes,” Journal of Nanoparticle Research, vol. 10, no. 8, pp. 1343–1348, 2008.

H. L. Karlsson, J. Gustafsson, P. Cronholm, and L. Möller, “Size-dependent toxicity of metal oxide particles—a comparison between nano- and micrometer size,” Toxicology Letters, vol. 188, no. 2, pp. 112–118, 2009.

I. R. Bell, J. A. Ives, and W. B. Jonas, “Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions,” Dose-Response, vol. 12, no. 2, pp. 202–232, 2014.

S. V. Stovbun, A. V. Kiselev, A. M. Zanin et al., “Effects of physicochemical forms of phenazepam and panavir on their action at ultra-low doses,” Bulletin of Experimental Biology and Medicine, vol. 153, no. 4, pp. 455–458, 2012.